Abnormal Cervical Cytology in Pregnancy: A Laboratory and Clinical Dermatologic Perspective

Huff, Beth

doi:10.1097/00005237-200006000-00005

Cited by 4 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Insufficient cellular material was the most likely cause for an unsatisfactory report (51.6%) in this study. Low cellular material is commonly associated with the Pap smear sampling technique (not applying enough pressure) and can be affected by hormonal changes to the cervix, in particular pregnancy 22 . The collectors in Efate were gynaecologists or gynaecology registrars with more experience at performing Pap smears compared with the nurses used in Ambae, who were hired from the Vanuatu Family Health Association.…”

Section: Discussionmentioning

confidence: 99%

Estimates for cervical abnormalities in Vanuatu

Fotinatos

Warmington

Walker

et al. 2007

Australian and New Zealand Journal of Public Health

View full text Add to dashboard Cite

Objective: To use the Pap smear to establish a recent prevalence of cervical abnormalities within a select population in Vanuatu, a developing country. Methods: Cervical smears (n=907) were collected from Ni‐Vanuatu women from both urban and rural islands within Vanuatu between August 2001 and September 2005. Results: The prevalence of low‐grade epithelial abnormalities for the total population was 2.9% and the prevalence of the high‐grade epithelial abnormalities/cancer was 2.0%. There was a significant difference (p<0.05) in prevalence of high‐grade epithelial abnormalities/cancer between the urban and rural populations sampled, with a higher prevalence in the urban population. Conclusions: The prevalence of pre‐cancer and cancer in Vanuatu is high compared with Victorian (Australian) statistics yet comparable with other developing countries with no cervical screening programs available. Implications: This study will hopefully assist in future planning of women's health programs and relevant preventive strategies to combat cervical cancer in Vanuatu.

show abstract

Section: Discussionmentioning

confidence: 99%

Estimates for cervical abnormalities in Vanuatu

Fotinatos

Warmington

Walker

et al. 2007

Australian and New Zealand Journal of Public Health

View full text Add to dashboard Cite

show abstract

“…Prior to the NHS CSP being introduced in 1988, cervical screening was often performed opportunistically in pregnancy, as part of routine pelvic examination at booking 29. However, interpretation of cervical cytology is more challenging in pregnancy and the puerperium,30 hence why routine screening, in those with a normal history, is deferred until after 12 weeks after pregnancy 31. Many of the women who require screening during pregnancy are those who have had recent colposcopic examination and/or treatment.…”

Section: Methodsmentioning

confidence: 99%

Improving the uptake of cervical screening in pregnant and recently postnatal women: a quality improvement project

et al. 2022

View full text Add to dashboard Cite

BackgroundIn 2018, cervical screening uptake was at its lowest level since screening began, particularly in those aged 25–35, coinciding with the peak incidence of cervical cancer and average age at first delivery.ProblemRetrospective baseline data of pregnant women found 47.3% (n=123/260) were overdue for screening by delivery, of whom 74% (n=91/123) remained overdue by 6 months postnatal.MethodsWe undertook a quality improvement project from April 2018 to April 2019 to improve cervical screening uptake in pregnant and postnatal women. We mapped out the screening process and canvassed stakeholders. The main theme was inconsistency of advice received by women. From February 2018 to May 2020, we undertook a prospective audit of 10 women per week who gave birth in our maternity department, recording screening status at delivery and 6 months postnatal.Interventions included introducing evidence-based guidelines about cervical screening in pregnancy and the postnatal period, flow charts for maternity staff, multiprofessional teaching for all maternity staff and information dissemination to women (via the HANDiApp platform, a social media campaign and adapting results letters following colposcopy, highlighting dates when screening would be due). Primary care opening hours were extended for screening and women received a letter from their midwives, if they required cervical screening in pregnancy.ResultsLocally, the percentage of women overdue for cervical screening by 6 months postnatal improved by 8.0% during this project, compared with a 1.6% change in national screening rates in women aged 25–49.ConclusionsWe increased the percentage of local pregnant and postnatal women attending cervical screening by introduction of a package of information, targeted education and widening access to screening appointments.

show abstract

“…24,25 There seems to be no evidence that pregnancy is associated with progression of cervical dysplasia to invasive cancer. 26 During pregnancy, warts may be safely treated with trichloroacetic acid, bichloroacetic acid, and all surgical therapies, including cryotherapy. 27,28 The effects of salicylic acid, podofilox, imiquimod, and cidofovir are unknown; podophyllin resin and topical 5-fluorouracil are not considered safe in pregnancy.…”

Section: Human Papillomavirusmentioning

confidence: 99%